Questa Bio SRL
Questa Bio reported total assets of 168,644 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Questa Bio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Questa Bio's annual accounts
| 2025 | |
|---|---|
| Net result | −25,018 € |
| Equity | −19,018 € |
| Cash | 166,225 € |
| EBITDA | −19,572 € |
| Total assets | 168,644 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
Questa Bio's financial analysis
- Solvency-11.3%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Questa Bio
Questa Bio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.743.841
- VAT number
- BE1012743841
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 23 Aug 2024
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Questa Bio (SRL) has been based in Uccle since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 25,018 € and equity of −19,018 €; its revenue is not published. Its solvency stands at -11.3%, below the median of its sector (45.7%).
Companies similar to Questa Bio
Companies in the same business, of comparable size and area, outside its group.
- JV forensische en medische expertise Research and experimental development on natural sciences and engineering Genk · balance sheet 128,664 €
- Nxtlab Research and experimental development on natural sciences and engineering Roeselare · balance sheet 119,190 €
- CRz Services Research and experimental development on natural sciences and engineering Spa · balance sheet 251,152 €
- Hans DE Vilder - Clinical Research Consultancy Research and experimental development on natural sciences and engineering Genk · balance sheet 267,868 €
- IDA International Research and experimental development on natural sciences and engineering Leuven · balance sheet 101,921 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- DR. Roelandt R. Health Research and experimental development on natural sciences and engineering Affligem · balance sheet 75,195 €
- Dr. Frank Chielens Algemene Geneeskunde Research and experimental development on natural sciences and engineering Ypres · balance sheet 68,508 €
Frequently asked questions about Questa Bio
What is the revenue of Questa Bio?
Questa Bio files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Questa Bio?
In Belgium, the VAT number is the company number prefixed with BE: BE1012743841 for Questa Bio, if the company is VAT-registered. Its company number (CBE) is 1012.743.841.
Where is the registered office of Questa Bio?
According to the CBE register, the registered office of Questa Bio is in 1180 Uccle.
What is the equity of Questa Bio?
At the close of the 2025 financial year, the equity of Questa Bio amounts to -19,018 €, a solvency of -11.3% of total assets.
Who manages Questa Bio?
The register lists 1 active mandates at Questa Bio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Questa Bio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →